Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients

European Journal of Heart Failure

Volumn 8, Issue 6, 2006, Pages 621-627

  Cortés, Raquel ^a   Portolés, Manuel ^a   Salvador, Antonio ^a   Bertomeu, Vicente ^b   García de Burgos, Fernando ^c   Martínez Dolz, Luis ^a   Lletí, Esther Roselló ^a   Climent, Vicente ^d   Jordán, Alejandro ^c   Payá, Rafael ^e   Sogorb, Francisco ^d   Rivera, Miguel ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b San Juan Hospital   (Spain)

^c Elche University Hospital   (Spain)

^d Hospital General   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Heart failure; Natriuretic peptides; Urine

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CARDIAC PATIENT; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; URINE LEVEL;

AGED; BIOLOGICAL MARKERS; CARDIAC OUTPUT, LOW; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33749997830     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.11.011     Document Type: Article

References (35)

1. Hobbs F.D., Jones M.I., Allan T.F., et al. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur J Heart 21 (2000) 1877-1887
2. Hasegawa K., Fujiwara H., Doyama K., et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 88 (1993) 372-380
3. Yamamoto K., Burnett J.C., Jougasaki M., et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28 (1996) 988-994
4. Hunt P.J., Richards A.M., Nicholls M.G., Yandle T.G., et al. Immunoreactive amino-terminal-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 47 (1997) 287-296
5. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 43 (2004) 416-422
6. Troughton R.W., Prior D.L., Pereira Jj., et al. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur J Heart 20 (1999) 1736-1744
7. Hunt P.J., Yandle T.G., Nicholls M.G., et al. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. BBRC 214 (1995) 1175-1183
8. Richards A.M., Doughty R., Nicholls M.G., et al., Australia-New Zealand Heart Failure Group. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 37 (2001) 1781-1787
9. Richards A.M., and Troughton R.W. NT-proBNP in heart failure: therapy decisions and monitoring. Eur J Heart Fail 6 (2004) 351-354
10. Nieminen M.S., Bohm M., Cowie M.R., et al., Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 26 (2005) 384-416
11. Mattingly M.T., Brandt R.R., Heublein D.M., et al. Presence of C-type natriuretic peptide in human kidney and urine. Kidney Int 46 (1994) 744-747
12. Franz M., Woloszczuk W., and Horl W.H. N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients. Transplantation 72 (2001) 89-94
13. Togashi K., Fujita S., and Kawakami M. Presence of brain natriuretic peptide in urine. Clin Chem 38 (1992) 322-323
14. Heringlake M., Heide C., Bahlmann L., et al. Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers. J Appl Physiol 97 (2004) 173-179
15. Ng L.L., Geeranavar S., Jennings S.C., et al. Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci 106 (2004) 129-133
16. Ng L.L., Loke I.W., Davies J.E., et al. Community Screening for left ventricular dysfunction using plasma and urinary natriuretic peptides. J Am Coll Cardiol 45 (2005) 1043-1050
17. Remme W.J., Swedberg K., and Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Eur J Heart Fail 4 (2002) 11-22
18. Rivera S., Sattler F.R., Boyd H., et al. Urinary cytokines for assessing inflammation in HIV-associated wasting. Cytokine 13 (2001) 305-313
19. Sirera R., Salvador A., Roldán I., Taléns R., González-Molina A., and Rivera M. Quantification of proinflammatory cytokines in the urine of congestive heart failure patients. Its relationship with plasma levels. Eur J Heart Fail 5 (2003) 27-31
20. Collinson P.O., Barnes S.C., Gaze D.C., et al. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 6 (2004) 365-368
21. Rivera M., Cortes R., and Salvador A. Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail 7 7 (2005 (Dec)) 1168-1170
22. Knox F.G., Mertz J.I., Burnett J.C., et al. Role of hydrostatic and oncotic pressures in renal sodium reabsorption. Circ Res 52 (1983) 491-500
23. Dyckner T., and Wester P.O. Salt and water balance in congestive heart failure. Acta Med Scand Suppl 707 (1986) 27-31
24. Kabat-Koperska J., Motyl W., Domanski L., et al. Methods of GFR determination-creatinine clearance after cimetidine administration in clinical practice. Acta Med Austriaca 31 (2004) 51-55
25. Vogt-Schaden M., Gagelmann M., Hock D., et al. Degradation of porcine brain natriuretic peptide (pBNP-26) by endoprotease-24.11 from kidney cortical membranes. Biochem Biophys Res Commun 161 (1989) 1177-1183
26. Mehra M.R., Uber P.A., Park M.H., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43 (2004) 1590-1595
27. Wang T.J., Larson M.G., Levy D., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 109 (2004) 594-600
28. Pfister R., Scholz M., Wielckens K., et al. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6 (2004) 289-293
29. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6 (2004) 257-260
30. McDonagh T.A., Holmer S., Raymond I., et al. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 6 (2004) 269-273
31. Wieczorek S.J., Wu A.H., Christenson R., et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 144 (2002) 834-839
32. Maisel A.S., Koon J., Krishnaswamy P., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141 (2001) 367-374
33. Seino Y., Ogawa A., Yamashita T., et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 6 (2004) 295-300
34. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
35. Maisel A., Hollander J.E., Guss D., et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 (2004) 1328-1333